The Metrix blog
Patient empathy as a field skill: Why rare disease reps need more than product training
A Specialist Representative sits across from a physician who has treated eleven patients with the indicated condition…
Metrix's top picks
Scaling without full confidence: The hidden cost of “Almost Ready” reps
Three months after approval, the Chief Commercial Officer wants an answer. Pull through is behind plan, the field team has been live for eight weeks, and every rep on the roster passed certification with a score above ninety. The training worked but the field performance is not hitting the mark. That is the conversation most…
Breaking silos in rare disease: How training drives cross-functional excellence
A field rep visits a treating specialist on a Tuesday….
The 5 training gaps we consistently find in market access field teams
A Field Reimbursement Manager sits across from a billing manager…
Why your FRM is still a trouble‑shooter, not a strategic partner, and what training has to do with it
Field Reimbursement Managers (FRMs) were never meant to be trouble-shooters….
Stay ahead of the game with regular updates
All results
Patient empathy as a field skill: Why rare disease reps need more than product training
A Specialist Representative sits across from a physician who has treated eleven patients with the indicated condition…
Scaling without full confidence: The hidden cost of “Almost Ready” reps
Three months after approval, the Chief Commercial Officer wants an answer. Pull through is behind plan, the…
Breaking silos in rare disease: How training drives cross-functional excellence
A field rep visits a treating specialist on a Tuesday. A field reimbursement manager (FRM) calls the…
The 5 training gaps we consistently find in market access field teams
A Field Reimbursement Manager sits across from a billing manager who wants a straight answer to a…
Why your FRM is still a trouble‑shooter, not a strategic partner, and what training has to do with it
Field Reimbursement Managers (FRMs) were never meant to be trouble-shooters. The role was created to shape access…
Five things LTEN 2026 confirmed about the direction of L&D in life sciences
LTEN 2026 surfaced something worth paying attention: the L&D conversation in life sciences has shifted. The questions…
Early launch training wins: How to spot success and gaps before the 90-day mark
By the time the first 90 days of launch are underway, most pharma launch teams already have…
The right-sized launch: How to prioritize training investment when budget is constrained
There is a version of this conversation that happens in almost every pre-commercial biotech. A VP of…
One team, one message: Building cross-functional collaboration into your product launch
Somewhere in a group practice right now, a rep is calling on a specialist. Two days later,…
The pharma post-launch training gap: Why field performance drops after the honeymoon phase
The national launch meeting is over. The field team has completed their training. They know the product,…
The reimbursement landscape just changed. Does your FRM team know what to tell their accounts?
Access is a critical driver of both launch success and long-term growth. When reimbursement rules shift, the…
Building field access capability from the ground up: Lessons from a launch-ready team
Field access has quietly become one of the most important levers in a successful launch. Yet in…